PubMed Health⌕ Search

Biomedical subjects

Brunon Woyczikowski

Publications and source records attributed to Brunon Woyczikowski.

2 recordsLinked to original sources

[Liposomes--therapeutic progress and technological problems].

Liposomes represent globular vesicles composed of an aqueous core and one or several phospholipid bilayers. They can encapsulate hydrophilic or lipophilic drugs used in therapy and diagnostic imaging. Liposomes provide protection of the active substances, sustained or controlled release and also targeted delivery of drugs to specific cells, tissues, organs. Easy oxydation of phosphatidylcholin (lecithin)--the main membrane component--is the limitation of the introduction of liposomes to the medicinal practice in a broader scale. Unsatisfying chemical stability of lecithin has an unfavourable influence on drug and liposome stability. Liposomes decompose during storage and leakage of the encapsulated drug occurs. A review of advantages of application of liposomes in medicine and methods of increasing their stability was presented.

Antineoplastic Combined Chemotherapy Protocols↗

The effect of cryoprotectants on the physical properties of large liposomes containing sodium diclofenac.

Large liposomes (1-10 microm) containing sodium diclofenac were prepared and lyophilized using lactose or mannitol (7.5% in respect to the lipid content) as cryoprotectants. The physical studies of liposomes were performed during 30 days of storage in a dry or resuspended form. Lyophilization of large liposomes and storage in the dry form at 5 degrees C increases their physical stability. Lactose is a cryoprotectant which does not influence changes of properties of liposomes regarding their size, encapsulation efficacy and release rate. Large liposomes lyophilized in the presence of mannitol tend to increase in size and encapsulation efficacy, but the lipid bilayers are stabilized and less permeable to the drug.

Cryoprotective Agents↗